Important

Research Use Notice

All articles and product information provided on this website are for informational and educational purposes only. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Any form of bodily introduction is strictly prohibited by law.

Product Documentation

Details, specifications, and reviews

Description

Prostamax 20 mg

Buy Prostamax 20 mg for laboratory research, supplied as lyophilized powder in one boxed 3 mL vial.

Prostamax is associated with the synthetic tetrapeptide Lys-Glu-Asp-Pro, abbreviated KEDP, in the research literature.

Identify the KEDP reference

The sequence specifies lysine, glutamic acid, aspartic acid and proline in that order. Other short peptides can share several residues while remaining different compounds. A matching prefix or the word bioregulator is not enough to substitute a material in an assay.

Compare the complete sequence, terminal groups and supplied chemical form with the study method. Evidence for an animal-tissue peptide extract should also be kept separate from evidence for a defined synthetic sequence.

Tissue culture and chromatin research

A 2006 study included Prostamax in comparisons of synthetic peptides using organotypic tissue cultures from young and old rats. The investigators examined responses in tissue explants, including prostate tissue, relative to controls. These were cultures maintained outside the animal, not a clinical prostate-health study.

A separate 2012 cell study explicitly identified the peptide as Lys-Glu-Asp-Pro. It measured chromosomal features in cells from older donors, including sister-chromatid exchanges and changes in condensed chromatin regions. Those measurements concern chromosome organization in a cell-culture experiment; they do not demonstrate rejuvenation or a treatment outcome in people.

What to check before selecting this material

Use the Documents tab to review the product files currently available. For batch qualification, confirm the lot and ask for any identity, purity or content evidence required by your method. A general product sheet or safety document is not a substitute for a lot-specific analytical result.

The 20 mg amount describes the powder presentation, not a concentration. Vial capacity does not determine the solvent volume, assay conditions or storage requirements. Those choices should follow information for the actual supplied form and the laboratory procedure. This item is a research material, not a finished medical formulation.

Need Assistance?

Questions about product documentation?

Our support team can assist with product records, lot information, order questions, and certificate verification.

Contact Support